To hear about similar clinical trials, please enter your email below
Trial Title:
Tracheal Tube and Swallowing After Head and Neck Surgery
NCT ID:
NCT05738421
Condition:
Dysphagia
Conditions: Official terms:
Deglutition Disorders
Study type:
Observational
Overall status:
Recruiting
Study design:
Time perspective:
Prospective
Intervention:
Intervention type:
Diagnostic Test
Intervention name:
fiberoptic endoscopic evaluation of swallowing
Description:
Questionnaire, FEES, OPES
Summary:
The present study was designed as a cross-sectional observational study providing the
enrollment of tracheostomized patients undergoing major oncological surgery for head-neck
cancer.
Aims:
- to provide objective data on the bolus transit during swallowing in tracheostomized
patients with tracheal tube and without tracheal tube closing directly the tracheal
stoma with a plaster, in order to sustain the choice to preserve the TT in dysphagic
patients after oncologic surgery for more security during swallowing rehabilitation
or adjuvant treatment.
- to evaluate the features of swallowing, specifically bolus transit, in patients
affected by head and neck cancer who underwent major oncological surgery.
Detailed description:
In the last twenty years, a wide and conflicting literature discussed about the impact of
the presence of a tracheal tube (TT), even if occluded, on the swallowing function. Early
the majority of authors agreed to target the tracheal tube as the cause of aspiration
basing on several mechanisms, first of all the decrease of laryngeal elevation.
Nevertheless over time, new researches had open to different results. In 2010 Leder et
al. [1] demonstrated the absence of a causal relationship between tracheotomy and
aspiration status in 25 patients who underwent fiberoptic endoscopic evaluation of
swallowing (FEES) and more recently Kang et al. [2] showed by Videofluoroscopic Swallow
Study (VFSS) that the swallowing parameters related to laryngeal elevation, pharyngeal
constriction, and esophageal opening did not changed significantly between patients with
and without tracheostomy. However until now the study samples and methods employed to
analyze the same purpose were heterogenous. At first the earlier researches were mostly
conducted immediately after tracheostomy, while the latest ones on cases with stabilized
tracheal stoma [3]. Furthermore, the possible mechanisms hypothesized to explain the
increased risk of aspiration were the same both for the studies about the effect of TT
occlusion status and the ones about the presence of TT. Dysphagia is a dysfunction that
deeply impacts especially the patient's post-surgery recovery, particularly dysphagia is
the most common short-term and long-term sequela in subjects undergoing head and neck
oncologic surgery. On this regard the tracheostomy and tracheal tube represent an
unquestionably security condition and a security device respectively. At a time when the
hospitalization is getting shorter and the swallowing rehabilitation training is mainly
carried out in the outpatient setting, it is even more important to clarify the real
impact of tracheal tube. Anyhow, to date the often-held assumption that tracheotomy and
placement of an occluded tracheotomy tube, by themselves, increase incidence of
aspiration was not supported by objective data. The objective of this project is to
evaluate, by mean of oropharyngoesophageal scintigraphy (OPES), the impact of an occluded
tracheal tube on swallowing of patients treated for head and neck cancer before hospital
discharge, to provide further knowledges especially useful for the out-patient care
management.
The present study was designed as a cross-sectional observational study providing the
enrollment of tracheostomized patients undergoing major oncological surgery for head-neck
cancer.
Criteria for eligibility:
Study pop:
In this study, a total of 20 tracheostomized patients undergoing primary major surgery
for head and neck cancer will be enrolled at the Otolaryngology hospitalization
department of the Fondazione Policlinico Univesitario A. Gemelli, in Rome (Italy)
Sampling method:
Probability Sample
Criteria:
Inclusion criteria
- Age >18 years
- Tracheal tube diameter of 5.0 mm and outside diameter of 9.4 mm
- Tolerance of the tracheal tube capping for almost 48 hours without pathologic
desaturation during continue monitoring of SpO2
- Ability to swallow in accordance to the inpatient training program
- Ability to suck with a straw without oral leakage Exclusion criteria
- Previous head and neck radiotherapy
- Patients with nasal tube feeding
- Patients with poor cognition or poor general condition or affected by neurological o
other nontumor-related dysphagia
- Patients total laryngectomized
- Patients unable to maintain the orthostatic position
Gender:
All
Minimum age:
18 Years
Maximum age:
70 Years
Locations:
Facility:
Name:
Maria Raffaella Marchese
Address:
City:
Roma
Zip:
00198
Country:
Italy
Status:
Recruiting
Contact:
Last name:
Jacopo Galli
Phone:
3338356370
Email:
jacopo.galli@policlinicogemelli.it
Contact backup:
Last name:
Maria Raffaella Marchese
Phone:
3391144556
Email:
raffaellamarchese@gmail.com
Start date:
December 6, 2021
Completion date:
October 6, 2026
Lead sponsor:
Agency:
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Agency class:
Other
Source:
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT05738421